Sources: to lessen its reliance on Safari for iOS, Google considered limiting AI Overviews to its own mobile apps, but ultimately decided against such a move
Sometime in the next few months, a judge is expected to rule on the U.S. Department of Justice's antitrust lawsuit against Google over its dominance of internet search.
Context & Ripple Effects
Google weighed whether to make a major AI search feature app-only on iOS, then kept it available through Safari. That choice preserves the existing web-distribution path while underscoring how dependent a search product can be on a platform it does not control.
The decision sits in a broader competition debate in which the search case was later framed as a contest over who controls AI’s next distribution layer, and the remedies discussion included ways to constrain Google’s search monopoly.
First-order effects
- AI Overviews remain available through Safari on iOS rather than becoming an exclusive feature of Google’s mobile apps.
- Google avoids an immediate product split between Safari users and users of its own iOS apps, but does not reduce its reliance on Safari-based reach.
Second-order effects
- Keeping a consistent Safari experience limits Google’s ability to use AI Overviews as a direct lever to move iPhone users into its apps.
- The episode makes distribution terms for AI search features more consequential in the antitrust debate: app exclusivity could alter access without changing the underlying search product.
Third-order effects
- If AI answers become a primary search interface, control of browser and operating-system access may matter as much as search quality in determining who reaches users.
- Antitrust remedies and platform-policy debates may increasingly examine whether AI features are broadly available or reserved for first-party surfaces; the eventual direction remains contingent on legal and product decisions.
The trend: AI search is turning distribution control—across browsers, operating systems, and first-party apps—into a central competitive and regulatory issue.